Form 4: UnitedHealth Group Director John H. Noseworthy Reports Acquisition of Common Stock

Director John H. Noseworthy reports acquiring 24 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Summary

• On December 17, 2024, John H. Noseworthy, a director of UnitedHealth Group, acquired 24 shares of common stock.
• The acquisition was due to dividend equivalents paid on vested deferred stock units.
• The price per share was $0.
• Following the transaction, Noseworthy beneficially owns 5,373 shares of UnitedHealth Group common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a routine transaction of dividend equivalents being converted into shares. It's a standard practice and doesn't necessarily indicate a significant positive or negative outlook.

Positives

• The acquisition of shares through dividend equivalents indicates a continued investment in the company by a director.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Key Dates